Clinical Trials Logo

Posttraumatic Confusional State clinical trials

View clinical trials related to Posttraumatic Confusional State.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT00693121 Completed - Clinical trials for Traumatic Brain Injury

Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State

Start date: April 2003
Phase: Phase 4
Study type: Interventional

Patients with traumatic brain injury often experience a period of acute confusion that may include agitation as they recover from their injuries. While this confusion generally resolves with time, patients may pose increased risk of injury to themselves or others during this period. Their behavior may also increase stress for family members and interfere with their ability to benefit from rehabilitation therapies. A number of different medications have been used to treat confusion to decrease agitation, decrease risk of injury, and improve participation in rehabilitation therapies. To this point, there has not been a research or scientific basis for knowing which medication is the best for a specific patient. The overall goal of this study is to conduct a scientific investigation to help determine which medication works best to treat confusion. Study hypothesis: Amantadine will reduce the severity and number of symptoms of acute confusion after traumatic brain injury.